石四药集团：吲哚菁绿获批登记成为在上市制剂使用的原料药

Core Viewpoint - The company Shijiazhuang Pharmaceutical Group (stock code: 02005) has received approval from the National Medical Products Administration of China for its indocyanine green to be used as an active pharmaceutical ingredient in marketed formulations [1] Group 1 - Indocyanine green is utilized for diagnosing various liver diseases, including cirrhosis, liver fibrosis, and drug-induced liver injury, as well as assessing liver damage and reserve function [1] - The compound is also applicable for choroidal vascular angiography to identify the location of choroidal disorders [1]